Herpes simplex virus (HSV) pneumonia in the non-ventilated immunocompromised host: Burden and predictors.


Journal

The Journal of infection
ISSN: 1532-2742
Titre abrégé: J Infect
Pays: England
ID NLM: 7908424

Informations de publication

Date de publication:
02 2019
Historique:
received: 15 04 2018
revised: 31 07 2018
accepted: 10 09 2018
pubmed: 30 9 2018
medline: 29 5 2020
entrez: 30 9 2018
Statut: ppublish

Résumé

To evaluate burden and predictors of HSV pneumonia among immunocompromised patients not undergoing invasive mechanical ventilation according to a tailored diagnostic algorithm. This prospective, observational study included immunocompromised adults with pneumonia non-responding to empirical antibiotic therapy. Bronchoalveolar lavage (BAL) specimens were cultured for bacteria, mycobacteria and fungi. Real-time PCR for Herpesviruses and other microorganisms were performed on BAL and other specimens. Cytological examination of BAL samples was carried out for identification of intranuclear inclusion bodies and immunohistochemical staining for HSV. We enrolled 45 patients (mean age 64.6 years) from January 2015 to June 2016. Nineteen (42.2%) cases tested positive for HSV-1 PCR on BAL. According to our definitions, 11 (24.4%) patients had HSV-1 pneumonia with viral loads ranging between 10 HSV pneumonia turned out to be relatively common and should be investigated especially in individuals with HSV positive throat swab and SOT. Interventional studies are needed to assess the real clinical impact of HSV pneumonia in immunocompromised patients.

Identifiants

pubmed: 30267802
pii: S0163-4453(18)30283-4
doi: 10.1016/j.jinf.2018.09.010
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

127-133

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2018. Published by Elsevier Ltd.

Auteurs

Roberto Luzzati (R)

Infectious Diseases Unit, University Hospital of Trieste, Piazza dell'Ospitale 1, 34125 Trieste, Italy. Electronic address: roberto.luzzati@asuits.sanita.fvg.it.

Pierlanfranco D'Agaro (P)

Laboratory for Hygiene and Public Health, University Hospital of Trieste, Strada di Fiume 447, 34149 Trieste, Italy.

Annalisa Busca (A)

Pulmonology Unit, University Hospital of Trieste, Strada di Fiume 447, 34149 Trieste, Italy.

Cristina Maurel (C)

Infectious Diseases Unit, University Hospital of Trieste, Piazza dell'Ospitale 1, 34125 Trieste, Italy.

Fulvia Martellani (F)

Anatomy and Histopathology Unit, University Hospital of Trieste, Strada di Fiume 447, 34149 Trieste, Italy.

Chiara Rosin (C)

Infectious Diseases Unit, University Hospital of Trieste, Piazza dell'Ospitale 1, 34125 Trieste, Italy.

Ludovica Segat (L)

Laboratory for Hygiene and Public Health, University Hospital of Trieste, Strada di Fiume 447, 34149 Trieste, Italy.

Giuseppe Gatti (G)

Cardiosurgery Unit, University Hospital of Trieste, Strada di Fiume 447, 34149 Trieste, Italy.

Marta Mascarello (M)

Infectious Diseases Unit, University Hospital of Trieste, Piazza dell'Ospitale 1, 34125 Trieste, Italy.

Marco Confalonieri (M)

Pulmonology Unit, University Hospital of Trieste, Strada di Fiume 447, 34149 Trieste, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH